SCHEMBL6769652

SCHEMBL6769652

CN(C)c1cc([N+](=O)[O-])ccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
TSHR P16473 5/20 0.42
LMNA P02545 1/20 0.42
TDP1 Q9NUW8 3/20 0.41
TP53 P04637 1/20 0.41
ACHE P22303 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNA4 P43681 1/20 0.40
CYP3A4 P08684 5/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
PDE2A O00408 1/20 0.39
PDE5A O76074 1/20 0.39
ALOX15 P16050 1/20 0.39
NFKB1 P19838 1/20 0.39
APEX1 P27695 1/20 0.39
PDE4A P27815 1/20 0.39
BLM P54132 1/20 0.39
PDE1B Q01064 1/20 0.39
PMP22 Q01453 1/20 0.39
PDE4B Q07343 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2144876 0.75 TSHR (0.50) ALDH1A1TSHRLMNATDP1ACHE
SCHEMBL826630 0.74 TSHR (0.50) ALDH1A1TSHRLMNATDP1TP53
SCHEMBL22151068 0.74 TP53 (0.39) ALDH1A1LMNATDP1TP53PDE4B
SCHEMBL3133571 0.74 APP (0.51) ALDH1A1TSHRLMNATDP1TP53
SCHEMBL2144585 0.73 CYP19A1 (0.47) ALDH1A1TSHRLMNACYP3A4MAPT
SCHEMBL28720537 0.72 TSHR (0.48) ALDH1A1TSHRLMNATDP1ACHE
SCHEMBL933269 0.72 PKM (0.57) ALDH1A1TSHRLMNATDP1ACHE
SCHEMBL30402495 0.72 PKM (0.57) ALDH1A1TSHRLMNATDP1ACHE
SCHEMBL2144959 0.72 TP53 (0.40) ALDH1A1LMNATP53L3MBTL1MAPT
SCHEMBL9274101 0.72 TP53 (0.49) ALDH1A1TP53L3MBTL1MEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6723726-B1 Protein tyrosine kinase inhibitors SMITHKLINE BEECHAM CORPORATION 2004-04-20 US disclosed
EP-0912570-B1 BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS GLAXO GROUP LTD (GB) 2003-09-10 EP disclosed
EP-1304110-A2 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors GLAXO GROUP LIMITED (GB) 2003-04-23 EP disclosed
US-6174889-B1 PROTEIN TYROSINE KINASE INHIBITORS RELATED TO BIOISOSTERES OF QUINOLINE AND QUINAZOLINE DERIVATIVES; ANTICARCINOGENIC AND -TUMOR AGENTS; PSORIASIS; RESTENOSIS; RHEUMATOID ARTHRITIS, AUTOIMMUNE DISEASE, ALLERGY, ASTHMA AND GRAFT REJECTION GLAXO WELLCOME INC. 2001-01-16 US disclosed